#4732
Expert Nurse
Rajni Kannan

We are now required under the OCM rules to meet a certain percentage of survivorship care plans per year. What I find interesting is that Medicare does not recognize stage IV patients as part of the OCM bundle for survivorship.

There is minimal information currently available about immunotherapy survivors in any of the cancers. Studies are needed to look at the finciancial, psychological, spirtitual and emotional long term side effects immunotherapy patients face along with residual physiological side effects.